JOANNE SOH: Open Payments
NPI 1932790441 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,440 in 86 payments from 15 companies in 2025. Trend: 2023 $876 · 2024 $2,008 · 2025 $1,440
Food & beverage: $1,365Education: $75
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $317 |
| Janssen Biotech, Inc. | 19 | $265 |
| Novartis Pharmaceuticals Corporation | 8 | $165 |
| GENZYME CORPORATION | 11 | $155 |
| Lilly USA, LLC | 6 | $114 |
| Regeneron Healthcare Solutions, Inc. | 4 | $111 |
| Amgen Inc. | 5 | $79 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $77 |
| UCB, Inc. | 2 | $42 |
| Organon LLC | 1 | $33 |
Products named: DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, COSENTYX, Otezla, Rhapsido, EBGLYSS.
Industry payments across OR — which companies pay providers there.
